Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy

Blood Plasma
Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy
Treatment with blood plasma from recovered patients is an accepted practice that goes back to the early 20th century.

Possible Remedy for the Coronavirus/Covid-19 Global Pandemic Invites Immediate Controversy.

On August 23, 2020 the Food and Drug Administration (FDA) announced a decision to grant blood plasma treatment for Coronavirus/Covid-19 patients with a fast-track authorization for its emergency use as a treatment for hospitalized COVID-19 patients.

The next day, claims about the effectiveness of this treatment were retracted. Subsequent news coverage about this potential treatment did little to clarify blood plasmas’ usefulness or lack thereof. The idea that there could be a political motivation behind the fast track authorization for this potential treatment, other than looking for a useful therapeutic, is troubling.

Who Can Americans Believe?

On his regular ‘Houston Healthcare Initiative’ podcast, respected neurologist Dr. Steven Goldstein defines how this decision triggered an outcry from scientists and doctors, who said the decision was not supported by adequate clinical evidence and criticized the FDA for what was perceived as bowing to ‘political pressure’.

Dr. Goldstein also reviews those who believed this approach was worthwhile. Generally, treatment with blood plasma from recovered patients is an accepted practice that goes back to the early 20th century. Many believe the possibility that blood plasma from recovered Coronavirus/Covid-19 patients could help people fight off the virus was worthy of further investigation.

Who is correct? Who should the American public rely on for the best information about treatment for this global health emergency?

The Houston Healthcare Initiative podcast can be heard on: SoundCloud, Apple Podcasts, Stitcher, Listen Notes, iHeartRadio, and the Houston Healthcare Initiative web site.

About Houston Healthcare Initiative And Dr. Steven Goldstein

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America. Blood plasma treatment for Covid-19 patients invites controversy.

The Reforms Big Pharmaceutical Companies Need

Reforms for the pharmaceutical industry.
Dr. Steven Goldstein has ideas that will make the pharmaceutical industry more responsive to the American public.

The Reforms Big Pharmaceutical Companies Need. On his regular podcast, Dr. Steven Goldstein advocated dramatic reforms for the pharmaceutical industry and with good reason. To hear the podcast go to: SoundCloud, iHeartRadio, Stitcher, Backtracks, LibSyn, or the website at www.houstonhealthcareinitiative.org. Dr. Goldstein insists that for the health and welfare of the American public, the congress must pass reforms that limit the influence of the pharmaceutical industry and its lobby.

What Has To Change – Ban Pharmaceutical Lobbying

“Corporate lobbying by pharmaceutical companies should be illegal,” Dr. Goldstein told his audience. “It isn’t right.” The companies who make more expensive treatments for ailments that could be treated with generic medicines spend millions of dollars lobbying the congress. According to a study by Brigham Young University, the health sector lobby’s spending increased more than 10% in the first quarter of 2020 while the non-health lobby sector increased 1%. Meanwhile, the number of new lobbyists registered in the health sector increased a staggering 140% while non-health sector registrations increased 63%.

Patent Reform

Drug companies should not be permitted to obtain patents because of small modifications to already existing patented medication. “That is not what the spirit of patent protection was meant for,” Dr. Goldstein said. He also advocates that existing antitrust laws be enforced to stop price fixing. “An example is the predatory practice of larger drug companies paying off small generic manufacturers in order to eliminate competition,” Dr. Goldstein said.

Prescription Reform; Physicians Prescribe Not Pharmacists or Bureaucrats

Physicians should be free to prescribe drugs “off-label” without fear of lawsuit or sanctions from state or federal regulatory boards. “Full stop, no questions from non-physicians, pharmacists or government regulators,” Dr. Goldstein stated.

FDA Reform

The Food and Drug Administration (FDA) is charged with making sure drugs are “safe and effective”. “If you think about it, there is no such thing as a drug that is 100% safe or 100% effective,” Dr. Goldstein said. “Even aspirin can cause gastritis and intestinal bleeding that in rare instances can cause death. Drugs used to treat epilepsy are only about 50% effective.  How then does the FDA decide what drugs to approve? After randomized controlled trials are performed, a panel of “experts” decides which drugs to approve.”

About Houston Healthcare Initiative and Dr. Steven Goldstein

Dr. Steven Goldstein is a Houston based neurologist. He founded the Houston Healthcare Initiative and is an advocate for common sense solutions to the healthcare crisis that confronts the citizens and residents of the United States of America. The Reforms Big Pharmaceutical Companies Need.